Protalix BioTherapeutics
PLX
#8698
Rank
S$0.22 B
Marketcap
S$2.82
Share price
0.92%
Change (1 day)
-17.61%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): S$0.02295

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is S$0.02572. In 2024 the company made an earnings per share (EPS) of S$0.05144 a decrease over its 2023 EPS that were of S$0.15.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.02295-55.39%
2024S$0.05144-66.67%
2023S$0.15-138.71%
2022S-$0.40-50%
2021S-$0.80181.82%
2020S-$0.28-82.11%
2019S-$1.58-31.67%
2018S-$2.31-72.31%
2017S-$8.36124.14%
2016S-$3.73-147.54%
2015S$7.85-290.63%
2014S-$4.126.67%
2013S-$3.86130.77%
2012S-$1.67-69.77%
2011S-$5.5319.44%
2010S-$4.63-12.2%
2009S-$5.2736.67%
2008S-$3.86-37.5%
2007S-$6.1750%
2006S-$4.123.23%
2005S-$3.99138.46%
2004S-$1.67-74%
2003S-$6.43-0%
2002S-$6.43-50%
2001S-$12.86233.33%
2000S-$3.86-84.21%
1999S-$24.44-24%
1998S-$32.15-600%
1997S$6.43-16.67%
1996S$7.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.75 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$6.20 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.59 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel